Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype

上皮性卵巢癌中卫星重复序列RNA的表达与肿瘤免疫抑制表型相关

阅读:2
作者:Rebecca L Porter ,Siyu Sun ,Micayla N Flores ,Emily Berzolla ,Eunae You ,Ildiko E Phillips ,Neelima Kc ,Niyati Desai ,Eric C Tai ,Annamaria Szabolcs ,Evan R Lang ,Amaya Pankaj ,Michael J Raabe ,Vishal Thapar ,Katherine H Xu ,Linda T Nieman ,Daniel C Rabe ,David L Kolin ,Elizabeth H Stover ,David Pepin ,Shannon L Stott ,Vikram Deshpande ,Joyce F Liu ,Alexander Solovyov ,Ursula A Matulonis ,Benjamin D Greenbaum ,David T Ting

Abstract

Aberrant expression of viral-like repeat elements is a common feature of epithelial cancers, and the substantial diversity of repeat species provides a distinct view of the cancer transcriptome. Repeatome profiling across ovarian, pancreatic, and colorectal cell lines identifies distinct clustering independent of tissue origin that is seen with coding gene analysis. Deeper analysis of ovarian cancer cell lines demonstrated that human satellite II (HSATII) satellite repeat expression was highly associated with epithelial-mesenchymal transition (EMT) and anticorrelated with IFN-response genes indicative of a more aggressive phenotype. SATII expression - and its correlation with EMT and anticorrelation with IFN-response genes - was also found in ovarian cancer RNA-Seq data and was associated with significantly shorter survival in a second independent cohort of patients with ovarian cancer. Repeat RNAs were enriched in tumor-derived extracellular vesicles capable of stimulating monocyte-derived macrophages, demonstrating a mechanism that alters the tumor microenvironment with these viral-like sequences. Targeting of HSATII with antisense locked nucleic acids stimulated IFN response and induced MHC I expression in ovarian cancer cell lines, highlighting a potential strategy of modulating the repeatome to reestablish antitumor cell immune surveillance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。